If we had to gamble on it, we’d bet the IPO market will be far more brisk this year than last year, which was the worst year for tech IPOs in particular since 2009. Even still, it came as a bit of a surprise today when not one or three but five biotech startups revealed plans to go public. (If you recall, biotech IPOs, which ticked along nicely for a couple of years, practically came… Read More...